PUBLISHER: The Business Research Company | PRODUCT CODE: 1939191
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939191
Active implantable medical devices (AIMDs) are entirely or partially embedded medical tools intended for diagnostic or therapeutic purposes, engineered to be permanently positioned within the human body.
These devices encompass a range of products including cardiac pacemakers, implantable cardioverter defibrillators (ICDs), nerve stimulators, cochlear implants, ventricular assist devices, among others. For instance, an implantable cardioverter-defibrillator (ICD) is a small, battery-powered device inserted into the chest to detect and regulate abnormal heart rhythms. They serve diverse applications such as cardiovascular, neurological treatments, aiding hearing impairment, and are employed by various end-users including hospitals, specialized clinics, and ambulatory surgical centers.
Tariffs are influencing the active implantable medical devices market by increasing costs of imported semiconductors, microelectronics, sensors, batteries, and precision manufacturing equipment. Manufacturers in North America and Europe are most affected due to complex global supply chains, while Asia-Pacific faces pricing pressure on exported implantable components. These tariffs are raising production costs and extending certification timelines. However, they are also driving localized electronics manufacturing, regional supplier partnerships, and innovation in cost-efficient implant design architectures.
The active implantable medical devices market research report is one of a series of new reports from The Business Research Company that provides active implantable medical devices market statistics, including active implantable medical devices industry global market size, regional shares, competitors with a active implantable medical devices market share, detailed active implantable medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the active implantable medical devices industry. This active implantable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The active implantable medical devices market size has grown strongly in recent years. It will grow from $27.95 billion in 2025 to $30.51 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to rising prevalence of cardiovascular and neurological disorders, early adoption of pacemakers and neurostimulators, advancements in battery technologies, improvements in implant biocompatibility, growing clinician familiarity with implantable systems.
The active implantable medical devices market size is expected to see strong growth in the next few years. It will grow to $42.81 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to expansion of remote patient monitoring solutions, rising demand for personalized implantable therapies, increasing integration of ai-enabled diagnostics, growth in aging population requiring chronic care, advancements in wireless power and communication technologies. Major trends in the forecast period include increasing integration of smart and connected implantable devices, rising adoption of miniaturized electronic components, growing use of data-driven therapeutic monitoring, expansion of long-term implantable therapies, enhanced focus on device longevity and reliability.
The active implantable medical devices market is poised for growth, driven by the increasing prevalence of cardiovascular diseases (CVD). Cardiovascular diseases encompass a range of conditions affecting the heart or blood vessels, often associated with factors such as atherosclerosis and an elevated risk of blood clots. Active implantable medical devices play a crucial role in regulating or monitoring irregular heartbeats in individuals with specific heart rhythm problems or heart failure. The surge in the incidence of cardiovascular diseases, notably due to the formation of fatty deposits and an increased risk of blood clots, is expected to propel the demand for active implantable medical devices. The rise in the geriatric population further contributes to this demand. For instance, in September 2025, according to the British Heart Foundation, a UK-based charity, over 7.6 million people in the UK-more than 4 million men and over 3.6 million women-are living with cardiovascular disease. Projections suggest that, driven by an aging population and improved survival rates, the number of individuals affected may increase by around 1 million by 2030 and by approximately 2 million by 2040. Therefore, the increase in cardiovascular diseases is driving the growth of the active implantable medical devices market.
Companies in the active implantable medical device market are also focused on developing technological advancements such as implantable PEEK filament to improve customization, enhance patient outcomes, and streamline production processes. Implantable PEEK filament is a specialized material created for making medical implants using additive manufacturing techniques. For instance, in March 2023, Invibio, a U.K.-based provider of high-performance implantable biomaterials, launched PEEK-OPTIMA AM filament. This filament is composed of implantable polyetheretherketone (PEEK) known for its biocompatibility and mechanical strength, making it ideal for implantable medical devices. The new filament is optimized for fused filament fabrication (FFF) and aims to enhance the production of medical devices, specifically designed for 3D printing applications in the medical field.
In December 2023, TekniPlex Healthcare, a U.S.-based manufacturer of medical device components, acquired Seisa Medical for an undisclosed amount. This acquisition allows TekniPlex to bolster its medical technology solutions platform, particularly in the minimally invasive and interventional therapy sectors. Seisa Medical is a U.S.-based manufacturer of active implantable medical devices.
Major companies operating in the active implantable medical devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co KG, LivaNova PLC, Cochlear Limited, MED-EL Medical Electronics, Sonova Holding AG, NeuroPace Inc, NEVRO Corp, Axonics Inc, Aleva Neurotherapeutics SA, MicroTransponder Inc, Shree Pacetronix, Berlin Heart GmbH, Jarvik Heart Inc, Blackrock Neurotech, Nurotron Biotechnology Co Ltd, CARMAT SA, Precision Neuroscience, Pins Medical, Lepu Medical Technology Co Ltd, LifeTech Scientific
North America was the largest region in the active implantable medical devices market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the active implantable medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the active implantable medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The active implanted medical devices market consists of sales of active implanted medical devices with components such as battery packs, controllers, implant kits, leads, programmers, and refill kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Active Implantable Medical Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses active implantable medical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for active implantable medical devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The active implantable medical devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.